비알코올성 지방간이 다른 내과질환에 미치는 임상적 영향

키워드

참고문헌 (46)

1. Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", J Gastroenterol Hepatol, 21, pp.138~143 (2006)
2. Brea A, "Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study", Arterioscler Thromb Vasc Biol, 25, pp.1045~1050 (2005)
3. Fracanzani AL, "Carotid artery intima-media thickness in nonalcoholic fatty liver disease", Am J Med, 121, pp.72~78 (2008)
4. Targher G, "Relation of nonalcoholic hepatic steatosis to earlycarotid atherosclerosis in healthy men: role of visceral fat accumulation", Diabetes Care, 27, pp.2498~2500 (2004)
5. Villanova N, "Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease", Hepatology, 42, pp.473~480 (2005)
6. Davignon J, "Role of endothelial dysfunction in atherosclerosis", Circulation, 109, pp.III27~III32 (2004)
7. Schindhelm RK, "Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease", Diabetes Metab Res Rev, 22, pp.437~443 (2006)
8. Targher G, "Increased prevalence of cardiovascular disease in Type 2 diabetic patients with nonalcoholic fatty liver disease", Diabet Med, 23, pp.403~409 (2006)
9. Lin YC, "Sonographic fatty liver, overweight and ischemic heart disease", World J Gastroenterol, 11, pp.4838~4842 (2005)
10. Sung KC, "The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects", Atherosclerosis (2008)
11. Ong JP, "Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease", J Hepatol, 49, pp.608~612 (2008)
12. Matteoni CA, "Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity", Gastroenterology, 116, pp.1413~1419 (1999)
13. Ekstedt M, "Long-term follow-up of patients with NAFLD and elevated liver enzymes", Hepatology, 44, pp.865~873 (2006)
14. Ioannou GN, "Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States", Hepatology, 43, pp.1145~1151 (2006)
15. Schindhelm RK, "Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study", Atherosclerosis, 191, pp.391~396 (2007)
16. Yki-Jarvinen H, "The fatty liver and insulin resistance", Curr Mol Med, 5, pp.287~295 (2005)
17. Marchesini G, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome", Diabetes, 50, pp.1844~1850 (2001)
18. Yesilova Z, "Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease", Am J Gastroenterol, 100, pp.850~855 (2005)
19. Targher G, "Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue", Diabet Med, 22, pp.1354~1358 (2005)
20. Matsuzawa Y, "Adiponectin and metabolic syndrome", Arterioscler Thromb Vasc Biol, 24, pp.29~33 (2004)
21. Pischon T, "Plasma adiponectin levels and risk of myocardial infarction in men", Jama, 291, pp.1730~1737 (2004)
22. Asselah T, "Steatosis in chronic hepatitis C: why does it really matter?", Gut, 55, pp.123~130 (2006)
23. Conjeevaram HS, "Race, insulin resistance and hepatic steatosis in chronic hepatitis C", Hepatology, 45, pp.80~87 (2007)
24. Adinolfi LE, "Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications", Aliment Pharmacol Ther, 22(2), pp.52~55 (2005)
25. Adinolfi LE, "Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity", Hepatology, 33, pp.1358~1364 (2001)
26. Bugianesi E, "Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis", Hepatology, 44, pp.1648~1655 (2006)
27. Gabriel A, "Hepatocyte steatosis in HCV patients promotes fibrosis by enhancing TGF-beta liver expression", Hepatol Res, 38, pp.141~146 (2008)
28. Piche T, "The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C", J Viral Hepat, 11, pp.91~96 (2004)
29. Fan JG, "Hepatitis B and fatty liver: causal or coincidental?", J Gastroenterol Hepatol, 23, pp.679~681 (2008)
30. Luo B, "Association of metabolic syndrome and hepatitis B infection in a Chinese population", Clin Chim Acta, 380, pp.238~240 (2007)
31. Jan CF, "A population-based study investigating the association between metabolic syndrome and hepatitis B", C infection (Keelung Community-based Integrated Screening study No. 10), 2006, pp.30, 794~799
32. Adams LA, "The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies", J Hepatol, 42, pp.132~138 (2005)
33. Sanyal AJ, "Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C", Hepatology, 43, pp.682~689 (2006)
34. Marrero JA, "NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States", Hepatology, 36, pp.1349~1354 (2002)
35. Caldwell SH, "Obesity and hepatocellular carcinoma", Gastroenterology, 127, pp.S97~S103 (2004)
36. Yang S, "Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?", Cancer Res, 61, pp.5016~5023 (2001)
37. El-Serag HB, "Hepatocellular carcinoma: epidemiology and molecular carcinogenesis", Gastroenterology, 132, pp.2557~2576 (2007)
38. Wideroff L, "Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark", J Natl Cancer Inst, 89, pp.1360~1365 (1997)
39. N'Kontchou G, "Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis", Clin Gastroenterol Hepatol, 4, pp.1062~1068 (2006)
40. Chen J, "The metabolic syndrome and chronic kidney disease in U.S. adults", Ann Intern Med, 140, pp.167~174 (2004)
41. Kurella M, "Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults", J Am Soc Nephrol, 16, pp.2134~2140 (2005)
42. Wolf G, "Leptin and renal disease", Am J Kidney Dis, 39, pp.1~11 (2002)
43. Kambham N, "Obesity-related glomerulopathy: an emerging epidemic", Kidney Int, 59, pp.1498~1509 (2001)
44. Friis-Liby I, "High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease", Scand J Gastroenterol, 39, pp.864~869 (2004)
45. Fan JG, "Effects of nonalcoholic fatty liver disease on the development of metabolic disorders", J Gastroenterol Hepatol, 22, pp.1086~1091 (2007)
46. Shibata M, "Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men", Diabetes Care, 30, pp.2940~2944 (2007)

관련 논문AI추천